About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 703 record(s)
Req # A-2023-000301
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Clinical Practice (GCP) inspection of the Merck…Organization: Health Canada
October 2023
Req # A-2023-000302
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP) inspection of…Organization: Health Canada
October 2023
Req # A-2023-000303
Provide the disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Pharmacovigilance Practices (GVP)…Organization: Health Canada
October 2023
Req # A-2023-000383
All emails between members of the Scientific Advisory Committee on Health Products for Women and/or between members of the Scientific Advisory Committee on Health Products for Women and the committee’s secretariat on the topic of breast implants.Organization: Health Canada
October 2023
Req # A-2023-000455
Every final Harassment and Violence investigation report completed during the period of April 1, 2021 to March 31, 2023.Organization: Health Canada
October 2023
Req # A-2023-000458
The disclosable inspection document(s) listing the Inspector’s detailed observations, conditions found, and any follow-up expected by Health Canada for the human drugs drug establishment licence Good Manufacturing Practices (GMP) inspection of the…Organization: Health Canada
October 2023
Req # A-2023-000473
All relevant documents from the following workstreams: Workstream D: Pollinator protection and neonicotinoid pesticides; Workstream E: Pest control emerging technologies related to the Canada-United States Regulatory Cooperation Council (RCC) for…Organization: Health Canada
October 2023
Req # A-2023-000493
All correspondence between Health Canada and Dr. Robert Casper and/or Toronto Centre for Advance Reproductive Technology (TCART) related to the Ovu Science company and/or AUGMENT intervention or study.Organization: Health Canada
October 2023
Req # A-2023-000737
All documents submitted in the medical device license application, resulting in Acro Biotech's Medical Device Licence (MDL)#108387, be provided.Organization: Health Canada
October 2023
Req # A-2023-000800
Criteria matrix for a modified hybrid work agreement under a duty to accommodate within the Controlled Substances and Cannabis Branch.Organization: Health Canada
October 2023